Log in to save to my catalogue

Nuclear receptors: emerging drug targets for parasitic diseases

Nuclear receptors: emerging drug targets for parasitic diseases

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5373876

Nuclear receptors: emerging drug targets for parasitic diseases

About this item

Full title

Nuclear receptors: emerging drug targets for parasitic diseases

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2017-04, Vol.127 (4), p.1165-1171

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Parasitic worms infect billions of people worldwide. Current treatments rely on a small group of drugs that have been used for decades. A shortcoming of these drugs is their inability to target the intractable infectious stage of the parasite. As well-known therapeutic targets in mammals, nuclear receptors have begun to be studied in parasitic worm...

Alternative Titles

Full title

Nuclear receptors: emerging drug targets for parasitic diseases

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5373876

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5373876

Other Identifiers

ISSN

0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI88890

How to access this item